SCHEMBL646175

SCHEMBL646175

O=C(O)CCNC(=O)C(c1ccccc1)C1CCCC1=O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA1 P00915 1/20 0.44
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MME P08473 1/20 0.41
ACE P12821 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL645083 0.88 ALDH1A1 (0.44) TP53CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL6264679 0.74 CA1 (0.48) TP53TDP1CA1RAB9AKDM4E
SCHEMBL9832121 0.71 CNR1 (0.69) TSHRRAB9AALDH1A1MMEACE
SCHEMBL11836972 0.70 MCL1 (0.54) TP53TDP1CA1RAB9AKDM4E
SCHEMBL14292324 0.70 MAPT (0.68) TP53CA1RAB9AKDM4ENPC1
SCHEMBL21274413 0.70 NAAA (0.62) MMEACE
SCHEMBL28789732 0.70 MAPT (0.68) TP53CA1RAB9AKDM4ENPC1
SCHEMBL3200580 0.68 ERCC1 (0.52) ALDH1A1MMEACE
SCHEMBL14540295 0.68 ERCC1 (0.52) ALDH1A1MMEACE
SCHEMBL9829773 0.67 HTR1E (0.64) TP53CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106536541-B Process for the preparation of ramipril 赛诺菲-安万特德国有限公司 2021-01-08 CN disclosed
US-10112973-B2 Process for the preparation of ramipril SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2018-10-30 US disclosed
EP-3154940-B1 PROCESS FOR THE PREPARATION OF RAMIPRIL SANOFI AVENTIS DEUTSCHLAND (DE) 2018-04-18 EP disclosed
US-20170158733-A1 PROCESS FOR THE PREPARATION OF RAMIPRIL SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2017-06-08 US disclosed
EP-3154940-A1 PROCESS FOR THE PREPARATION OF RAMIPRIL Sanofi-Aventis Deutschland GmbH (DE) 2017-04-19 EP disclosed
WO-2015189108-A1 PROCESS FOR THE PREPARATION OF RAMIPRIL SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2015-12-17 WO disclosed
US-8119375-B2 Method for the production of ramipril SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2012-02-21 US disclosed
US-20090017509-A1 METHOD FOR THE PRODUCTION OF RAMIPRIL SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2009-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10112973-B2 Process for the preparation of ramipril CYP2S1, CYP3A5, CYP4B1 TP53 4868/4885CYP1A2 4/4885CYP3A4 5/4885
US-20090017509-A1 METHOD FOR THE PRODUCTION OF RAMIPRIL REN, PDE8B, PDE3A TP53 4824/4885CYP1A2 59/4885CYP3A4 37/4885
US-20170158733-A1 PROCESS FOR THE PREPARATION OF RAMIPRIL CYP2S1, CYP3A5, CYP4B1 TP53 4868/4885CYP1A2 4/4885CYP3A4 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.